The University of Chicago Header Logo

Connection

Robert Gibbons to Fluoxetine

Back to Details
This is a "connection" page, showing publications Robert Gibbons has written about Fluoxetine.
Robert Gibbons
Connection Strength
1.778
Fluoxetine
  1. Inappropriate data and measures lead to questionable conclusions--reply. JAMA Psychiatry. 2013 Jan; 70(1):122-3.
    View in: PubMed
    Score: 0.422
  2. Suicide risk and efficacy of antidepressant drugs--reply. JAMA Psychiatry. 2013 Jan; 70(1):123-5.
    View in: PubMed
    Score: 0.422
  3. Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Arch Gen Psychiatry. 2012 Jun; 69(6):580-7.
    View in: PubMed
    Score: 0.405
  4. Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Arch Gen Psychiatry. 2012 Jun; 69(6):572-9.
    View in: PubMed
    Score: 0.405
  5. Multiple imputation for harmonizing longitudinal non-commensurate measures in individual participant data meta-analysis. Stat Med. 2015 Nov 20; 34(26):3399-414.
    View in: PubMed
    Score: 0.125
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.